Full access

LETTER

Published Online: 1 October 2007

Pathological Gambling Associated With Cabergoline Therapy in a Patient With a Pituitary prolactinoma.

Michael DavieAuthors Info & Affiliations

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

https://doi.org/10.1176/jnp.2007.19.4.473

SIR: I report the case of a 47-year-old woman with pathological gambling associated with low dose cabergoline treatment for pituitary prolactinoma.

The patient was a previously well woman with no psychiatric history and no previous history of gambling. She was diagnosed with a pituitary prolactinoma at 25 years of age after investigations for infertility and was initially successfully treated with bromocriptine. It was taken for some years and then stopped.

At 38 years of age she developed recurrent lactation, ongoing irregular menses and hyperprolactaemia. Repeat MRI confirmed a pituitary microadenoma and cabergoline was commenced at a dose of 0.25 mg weekly. Menses then became regular, galactorrhea improved and prolactin returned to within the normal range. Nausea was reported and surgical treatment offered but declined.

Approximately 1 year later she began gambling on poker machines and this behavior escalated over the next 9 years. She gambled on most days and lost approximately $700,000 in total. As her gambling increased she developed depression, paranoia, and marital difficulty. She was commenced on Alendronate sodium at the age of 46 because of osteopenia.

At the time of presentation, the diagnoses of major depression with paranoid delusions and pathological gambling were made. Her cabergoline was ceased and an antidepressant, escitalopram was commenced. Two months later her mood had improved, her paranoid delusions had resolved, and her gambling had ceased. Surgical management of her prolactinoma will now be reconsidered.

Cabergoline is a dopamine ergoline derivative which stimulates D2 receptors in the pituitary. 1 It has been proposed that pathological gambling is caused by a stimulation of dopaminergic reward systems and is linked with other addictive and obsessive behaviors. 2 Cabergoline has been associated with pathological gambling when used with L -dopa to treat Parkinson’s disease. 3

To my knowledge, this is the first report of cabergoline being associated with pathological gambling in a patient with pituitary prolactinoma. Physicians prescribing cabergoline need to be aware of the potential for the development of pathological gambling in their patients.

References

Prescribing Information for cabergoline. eMIMS 2006.

Google Scholar

Schultz W. Getting formal with dopamine and reward. Neuron 2002; 36:241–263

Google Scholar

Avanzi M, Uber E, Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease. Neurol Sci 2004; 25:98–101

Google Scholar

Information & Authors

Information

Published In

The Journal of Neuropsychiatry and Clinical Neurosciences

Volume 19 • Number 4 • Fall, 2007

Pages: 473 - 474

PubMed: 18070857

History

Published online: 1 October 2007

Published in print: Fall, 2007

Authors

Affiliations

Michael Davie

The Hobart Clinic, Rokeby, Tasmania, Australia

View all articles by this author

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format	RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks
Direct importt
Citation style
Style

Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR^® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Pathological Gambling Associated With Cabergoline Therapy in a Patient With a Pituitary prolactinoma.

References